TISSUE MODULATION SYSTEMS

DE602020043490T2Active Publication Date: 2024-12-18RELIEVANT MEDSYSTEMS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602020043490
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-09-12
Filing Date
2020-09-10
Publication Date
2024-12-18
Estimated Expiration
2040-09-10

AI Technical Summary

Technical Problem

Current treatments for chronic lower back pain are often costly, addictive, temporary, and ineffective, with limited surgical eligibility and inadequate relief for most patients, and lack effective methods for real-time assessment of nerve ablation efficacy.

Method used

The use of biomarkers to assess pain and nerve ablation efficacy, combined with robotic systems for precise nerve modulation, including radiofrequency energy delivery to create specific lesion shapes within vertebral bodies, facilitating minimally invasive and accurate treatment of the basivertebral nerve.

Benefits of technology

This approach provides a safe, effective, and minimally invasive method for chronic lower back pain relief by quantitatively assessing treatment efficacy and allowing for precise nerve modulation, reducing recovery time and complications.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.